A significant increase in CTLA-4 expression was detected on B cells in patients with CLL (3.630 ± 2.897) compared to the control group (1.919 ± 1.184; p = 0.0241) (Figure 3B). This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.